<DOC>
	<DOCNO>NCT00361907</DOCNO>
	<brief_summary>The purpose study determine effect Pulsatile Intravenous Insulin therapy circulate blood marker . These blood marker select due correlation possible pathogenetic role vascular compromise inflammatory malfunction diabetic patient .</brief_summary>
	<brief_title>Effect Pulsatile IV Insulin Circulating Risk Markers Vascular Metabolic Complications Pts With Diabetes</brief_title>
	<detailed_description>Insulin produce vasodilatory , anti inflammatory anti thrombotic effect ( 1-4 ) . . However effect pulsatile intravenous insulin delivery circulate risk factor vascular metabolic disease unknown . This study use evaluate circulate risk marker vascular metabolic disease compare match control group . Protocol Patients select diabetes mellitus , 20 year age old , treated oral agent and/or insulin . The study minimum 12 month may continue 2-3 year significant difference show follow initial 12 month . Blood marker determine every 12 month first year , every 12 month . They may include follow : BNP , fructosamine , PAI-1 , fibrinogen , homocysteine , endothelin 1 , aldosterone , VCAM , ICAM , IGF-1 , TGF-beta , TNF-alpha , hs-CRP , IL-6 ) . The result compare age fructosamine match control group . Endpoints ; Changes marker Statistics : ANOVA Blood : 2 purple , 2 red , 2 blue top The respiratory quotient ( RQ ) measurement CO2 exhale O2 inhale proportionate fuel source use body , primarily liver short period time . The high RQ , glucose less alternative fuel source utilize . Following RQ change help determine effectiveness physiological insulin administration increase anabolic function diabetic individual . By improve body 's glucose metabolism thereby cause beneficial effect anabolic factor , possibility serious complication decrease . In addition use oral carbohydrate time along physiologic insulin administration stimulate appropriate gut hormone augment effect , response duplicate intravenous glucose . The purpose study determine whether physiologic administration pulsatile intravenous insulin along augment effect oral carbohydrate normalize metabolism diabetic patient improve quality life index . The RQ determine use metabolic cart . Individuals breathe mask 3-5 minute rest period 30 minute . The ratio exhale volume CO2 inhale volume O2 determine RQ . The physiologic range 0.7 to1.3 . Individuals use fat primary fuel ratio 0.7 , protein mixed fuel 0.8-0.9 carbohydrate 0.9-1.0 . Those take excessive calorie RQ 's high 1.05 . The RQ follow serially do twice , treatment , 3 successive session single treatment day . The amount intravenous insulin oral glucose give determine RQ change previous session . Pusatile intravenous insulin delivery process encourages glucose metabolism diabetic normalize multiple organ , especially muscle , retina , liver , kidney nerve ending . The process fundamentally require administration high dose intravenous insulin pulse similar find non diabetic human pancreas surround portal circulation . Oral carbohydrate give simultaneously augment process prevent hypoglycemia . The process monitor frequent glucose level measurement respiratory quotient ( RQ ) . RQ measure metabolic cart determines ratio VCO2/ VO2 . This ratio specific fuel use one time body . The glucose level monitor keep glucose level appropriate RQ determines need readjust infusion protocol patient subsequent insulin infusion session . Pulsatile intravenous insulin delivery do 1-hour period 1-hour rest period session three course day activation . References : Katakam PVG , Tulbert CD , Snipes JA , Erdos B , Miller AW , Busija DW , Impaired Insulin-induced Vasodilation Small Coronary Arteries Zucker Obese rat Mediated Reactive Oxygen Species , AJP-Heart 288:854-60 , 2005 . Chakraborty K Sinha AK , The Role Insulin Antithrombotic Humoral Factor , BioEssays 26:91-98 , 2003 . Elias AN , Eng S , Homocysteine Concentrations Patients Diabetes Mellitus-Relationship Microvascular Macrovascular Disease , Diabetes , Obesity Metabolism 7:117-21 , 2005 . Patiag D , Qu X , Gray S , Idris I , Wilkes M , Seale JP , Donnely R , Possible Interactions Angiotensin II Insulin : Effects Glucose Lipid Metabolism vivi vitro , Journal Endocrinology 167 : 525-31 , 2000</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>We include 500 patient male female age 21 diagnose type 1 type 2 diabetes mellitus All patient must secondary complication cause diabetes respond conventional medical management Under Endocrinologists supervision diabetes management Endocrinologist must assess approve patient participation study Ability swallow without difficulty Ability commit weekly time requirement associate study Other cause complication related diabetes Lack intravenous access Pregnancy Alcohol abuse , drug addiction use illegal drug Positive HIV Inability perform breathe machine respiratory quotient</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Pulsatile intravenous insulin</keyword>
	<keyword>Oral carbohydrate loading</keyword>
	<keyword>Respiratory Quotients</keyword>
	<keyword>Hypoglycemia</keyword>
	<keyword>Diabetic Complications</keyword>
	<keyword>Circulating vascular inflammatory marker</keyword>
</DOC>